Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Eledon Pharmaceuticals, Inc. | d832380d10k.htm |
| EX-32.2 - EX-32.2 - Eledon Pharmaceuticals, Inc. | d832380dex322.htm |
| EX-31.1 - EX-31.1 - Eledon Pharmaceuticals, Inc. | d832380dex311.htm |
| EX-32.1 - EX-32.1 - Eledon Pharmaceuticals, Inc. | d832380dex321.htm |
| EX-31.2 - EX-31.2 - Eledon Pharmaceuticals, Inc. | d832380dex312.htm |
| EX-10.14 - EX-10.14 - Eledon Pharmaceuticals, Inc. | d832380dex1014.htm |
| EX-10.18 - EX-10.18 - Eledon Pharmaceuticals, Inc. | d832380dex1018.htm |
| EX-10.20 - EX-10.20 - Eledon Pharmaceuticals, Inc. | d832380dex1020.htm |
| EX-10.16 - EX-10.16 - Eledon Pharmaceuticals, Inc. | d832380dex1016.htm |
| EX-10.12 - EX-10.12 - Eledon Pharmaceuticals, Inc. | d832380dex1012.htm |
| EX-10.10 - EX-10.10 - Eledon Pharmaceuticals, Inc. | d832380dex1010.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Eledon Pharmaceuticals, Inc. | Financial_Report.xls |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-200413) of Tokai Pharmaceuticals, Inc. of our report dated March 26, 2015 relating to the consolidated financial statements, which appear in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
March 26, 2015